NOVARTIS AG-REGNOVARTIS AG-REGNOVARTIS AG-REG

NOVARTIS AG-REG

No trades
See on Supercharts

Price target

101.160.00 0.00%
The 19 analysts offering 1 year price forecasts for NOVNZ have a max estimate of — and a min estimate of —.

Analyst rating

Based on 26 analysts giving stock ratings to NOVNZ in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

NOVNZ EPS for the last quarter is 1.62 CHF despite the estimation of 1.51 CHF. In the next quarter EPS is expected to reach 1.65 CHF. Track more of NOVARTIS AG-REG financials and stay on top of what is up with the company.
In the next quarter NOVARTIS AG-REG revenue is expected to reach ‪11.11 B‬ CHF. Check out NOVARTIS AG-REG revenue and earnings and make informed decisions.
According to analysts, NOVNZ price target is 101.16 CHF with a max estimate of 120.37 CHF and a min estimate of 74.82 CHF. Check if this forecast comes true in a year, meanwhile watch NOVARTIS AG-REG stock price chart and keep track of the current situation with NOVNZ news and stock market news.
We've gathered opinions of 26 analysts rating NOVNZ stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.